NASDAQ:OFIX - Orthofix Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$54.11 +0.02 (+0.04 %)
(As of 05/23/2018 11:01 AM ET)
Previous Close$53.01
Today's Range$53.01 - $54.11
52-Week Range$41.46 - $61.86
Volume1,029 shs
Average Volume177,287 shs
Market Capitalization$1.03 billion
P/E Ratio33.39
Dividend YieldN/A
Beta0.25

About Orthofix (NASDAQ:OFIX)

Orthofix logoOrthofix International N.V., a medical device company, provides musculoskeletal healing products and value-added services worldwide. It operates through four segments: BioStim, Extremity Fixation, Spine Fixation, and Biologics. The BioStim segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spine fractures. The Extremity Fixation segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The Spine Fixation segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. Orthofix International N.V. was founded in 1987 and is headquartered in Lewisville, Texas.

Receive OFIX News and Ratings via Email

Sign-up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
SymbolNASDAQ:OFIX
CUSIPN6748L10
Phone599-9-4658525

Debt

Debt-to-Equity RatioN/A
Current Ratio4.04
Quick Ratio2.85

Price-To-Earnings

Trailing P/E Ratio33.39
Forward P/E Ratio32.60
P/E Growth3.4

Sales & Book Value

Annual Sales$433.82 million
Price / Sales2.34
Cash Flow$2.8007 per share
Price / Cash19.32
Book Value$16.70 per share
Price / Book3.24

Profitability

EPS (Most Recent Fiscal Year)$1.62
Net Income$6.22 million
Net Margins3.21%
Return on Equity11.08%
Return on Assets8.28%

Miscellaneous

Employees858
Outstanding Shares18,760,000

Orthofix (NASDAQ:OFIX) Frequently Asked Questions

What is Orthofix's stock symbol?

Orthofix trades on the NASDAQ under the ticker symbol "OFIX."

How were Orthofix's earnings last quarter?

Orthofix (NASDAQ:OFIX) issued its earnings results on Monday, April, 30th. The medical device company reported $0.39 EPS for the quarter, beating the Zacks' consensus estimate of $0.36 by $0.03. The medical device company earned $108.71 million during the quarter, compared to the consensus estimate of $107.10 million. Orthofix had a return on equity of 11.08% and a net margin of 3.21%. Orthofix's quarterly revenue was up 5.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.27 earnings per share. View Orthofix's Earnings History.

When is Orthofix's next earnings date?

Orthofix is scheduled to release their next quarterly earnings announcement on Monday, August, 6th 2018. View Earnings Estimates for Orthofix.

What guidance has Orthofix issued on next quarter's earnings?

Orthofix updated its FY18 earnings guidance on Monday, April, 30th. The company provided earnings per share (EPS) guidance of $1.58-1.68 for the period, compared to the Thomson Reuters consensus estimate of $1.62. The company issued revenue guidance of $458-464, compared to the consensus revenue estimate of $460.20 million.Orthofix also updated its Q2 guidance to $0.35-0.37 EPS.

What price target have analysts set for OFIX?

6 brokerages have issued twelve-month price objectives for Orthofix's shares. Their forecasts range from $53.25 to $67.00. On average, they anticipate Orthofix's share price to reach $56.90 in the next year. View Analyst Ratings for Orthofix.

Who are some of Orthofix's key competitors?

Who are Orthofix's key executives?

Orthofix's management team includes the folowing people:
  • Mr. Bradley R. Mason, Pres, CEO & Director (Age 64)
  • Mr. Doug Rice, CFO & Chief Accounting Officer (Age 52)
  • Mr. Michael M. Finegan, Chief Strategy Officer (Age 54)
  • Mr. Bradley V. Niemann, Pres of BioStim Bus. (Age 48)
  • Mr. Davide Bianchi, Pres of Global Extremity Fixation (Age 53)

Has Orthofix been receiving favorable news coverage?

Headlines about OFIX stock have been trending somewhat negative this week, Accern Sentiment reports. Accern identifies positive and negative press coverage by monitoring more than twenty million news and blog sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Orthofix earned a daily sentiment score of -0.19 on Accern's scale. They also assigned news coverage about the medical device company an impact score of 46.46 out of 100, meaning that recent press coverage is somewhat unlikely to have an impact on the company's share price in the next few days.

Who are Orthofix's major shareholders?

Orthofix's stock is owned by a variety of of institutional and retail investors. Top institutional investors include BlackRock Inc. (14.14%), Dimensional Fund Advisors LP (4.68%), Segall Bryant & Hamill LLC (3.54%), Millennium Management LLC (3.13%), Diamond Hill Capital Management Inc. (2.28%) and Paradice Investment Management LLC (1.32%). Company insiders that own Orthofix stock include Brad Mason, Bradley V Niemann, Luke T Faulstick, Maria Sainz, Michael Finegan, Raymond Fujikawa, Rice Doug and Ronald A Matricaria. View Institutional Ownership Trends for Orthofix.

Which institutional investors are selling Orthofix stock?

OFIX stock was sold by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., Millennium Management LLC, Diamond Hill Capital Management Inc., American Century Companies Inc., Segall Bryant & Hamill LLC, California Public Employees Retirement System, Allianz Asset Management GmbH and Citigroup Inc.. Company insiders that have sold Orthofix company stock in the last year include Brad Mason, Bradley V Niemann, Luke T Faulstick, Raymond Fujikawa and Rice Doug. View Insider Buying and Selling for Orthofix.

Which institutional investors are buying Orthofix stock?

OFIX stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., Wells Fargo & Company MN, Paradice Investment Management LLC, Tygh Capital Management Inc., Russell Investments Group Ltd., GSA Capital Partners LLP, Argent Capital Management LLC and Summit Global Investments. View Insider Buying and Selling for Orthofix.

How do I buy shares of Orthofix?

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Orthofix's stock price today?

One share of OFIX stock can currently be purchased for approximately $53.94.

How big of a company is Orthofix?

Orthofix has a market capitalization of $1.03 billion and generates $433.82 million in revenue each year. The medical device company earns $6.22 million in net income (profit) each year or $1.62 on an earnings per share basis. Orthofix employs 858 workers across the globe.

How can I contact Orthofix?

Orthofix's mailing address is 7 ABRAHAM DE VEERSTRAAT, WILLEMSTAD P8, . The medical device company can be reached via phone at 599-9-4658525 or via email at [email protected]


MarketBeat Community Rating for Orthofix (OFIX)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  234 (Vote Outperform)
Underperform Votes:  281 (Vote Underperform)
Total Votes:  515
MarketBeat's community ratings are surveys of what our community members think about Orthofix and other stocks. Vote "Outperform" if you believe OFIX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OFIX will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Orthofix (NASDAQ:OFIX) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
6 Wall Street analysts have issued ratings and price targets for Orthofix in the last 12 months. Their average twelve-month price target is $56.90, suggesting that the stock has a possible upside of 5.16%. The high price target for OFIX is $67.00 and the low price target for OFIX is $53.25. There are currently 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $56.90$56.90$53.30$53.30
Price Target Upside: 5.16% upside1.34% upside6.92% upside6.92% upside

Orthofix (NASDAQ:OFIX) Consensus Price Target History

Price Target History for Orthofix (NASDAQ:OFIX)

Orthofix (NASDAQ:OFIX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/5/2018SunTrust BanksBoost Price TargetBuy$67.00HighView Rating Details
2/28/2018GabelliReiterated RatingBuyLowView Rating Details
10/30/2017BTIG ResearchSet Price TargetBuy$56.00N/AView Rating Details
8/10/2017Jefferies GroupReiterated RatingBuy$50.00 ➝ $55.00LowView Rating Details
6/14/2017Langenberg & CompanyReiterated RatingBuy$53.25LowView Rating Details
6/14/2017Ladenburg ThalmannInitiated CoverageBuy ➝ Buy$53.25LowView Rating Details
(Data available from 5/23/2016 forward)

Earnings

Orthofix (NASDAQ:OFIX) Earnings History and Estimates Chart

Earnings by Quarter for Orthofix (NASDAQ:OFIX)

Orthofix (NASDAQ:OFIX) Earnings Estimates

2018 EPS Consensus Estimate: $1.63
2019 EPS Consensus Estimate: $2.01
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20182$0.32$0.40$0.36
Q2 20182$0.35$0.36$0.36
Q3 20182$0.43$0.45$0.44
Q4 20182$0.47$0.48$0.48
Q1 20191$0.36$0.36$0.36
Q2 20191$0.48$0.48$0.48
Q3 20191$0.56$0.56$0.56
Q4 20191$0.61$0.61$0.61

Orthofix (NASDAQ OFIX) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/6/2018$0.37N/AView Earnings Details
4/30/2018Q1 2018$0.36$0.39$107.10 million$108.71 millionViewListenView Earnings Details
2/26/2018Q4 2017$0.50$0.52$116.93 million$116.90 millionViewListenView Earnings Details
10/30/2017Q3 2017$0.41$0.42$100.67 million$105.30 millionViewN/AView Earnings Details
8/7/2017Q2 2017$0.41$0.42$102.94 million$108.90 millionViewListenView Earnings Details
5/4/2017Q1 2017$0.27$0.27$97.17 million$102.70 millionViewListenView Earnings Details
2/27/2017Q416$0.37$0.42$106.07 million$108.50 millionViewListenView Earnings Details
10/31/2016Q316$0.34$0.36$103.40 million$98.50 millionViewListenView Earnings Details
8/1/2016Q216$0.33$0.41$102.40 million$104.10 millionViewN/AView Earnings Details
4/28/2016Q116$0.15$0.28$93.10 million$98.70 millionViewListenView Earnings Details
2/29/2016Q415$0.23$0.28$102.43 million$104.60 millionViewListenView Earnings Details
11/3/2015Q315$0.13$0.30$96.67 million$101.20 millionViewListenView Earnings Details
8/4/2015Q215$0.09$0.36$96.22 million$101.00 millionViewListenView Earnings Details
5/18/2015Q115$0.08($0.15)$89.50 million$89.80 millionViewListenView Earnings Details
4/29/2015Q414$0.30($0.05)$108.00 million$100.30 millionViewN/AView Earnings Details
3/31/2015$0.22$0.17$95.80 million$101.00 millionViewN/AView Earnings Details
5/7/2014Q1$0.22$0.29$101.10 million$101.34 millionViewN/AView Earnings Details
3/27/2014Q213($0.12)$117.40 million$106.10 millionViewListenView Earnings Details
5/8/2013Q1 2013$0.66$0.23$111.22 million$100.30 millionViewN/AView Earnings Details
2/21/2013Q4 2012$0.80$0.81$117.47 million$112.04 millionViewN/AView Earnings Details
10/24/2012$0.74$0.76ViewN/AView Earnings Details
7/26/2012$0.72$0.78ViewN/AView Earnings Details
4/26/2012$0.66$0.69ViewN/AView Earnings Details
2/23/2012$0.73$0.80ViewN/AView Earnings Details
10/27/2011$0.65$0.67ViewN/AView Earnings Details
7/28/2011$0.63$0.69ViewN/AView Earnings Details
5/5/2011$0.55$0.59ViewN/AView Earnings Details
2/15/2011$0.41$0.44ViewN/AView Earnings Details
10/27/2010Q3 2010$0.43$0.48ViewN/AView Earnings Details
7/28/2010Q2 2010$0.47$0.54ViewN/AView Earnings Details
4/28/2010Q1 2010$0.81$0.99ViewN/AView Earnings Details
2/17/2010Q4 2009$0.50$0.53ViewN/AView Earnings Details
10/29/2009Q3 2009$0.34$0.44ViewN/AView Earnings Details
7/30/2009Q2 2009$0.24$0.42ViewN/AView Earnings Details
5/6/2009Q1 2009$0.16$0.36ViewN/AView Earnings Details
2/12/2009Q4 2008$0.29$0.40ViewN/AView Earnings Details
11/6/2008Q3 2008$0.03$0.34ViewN/AView Earnings Details
8/7/2008Q2 2008$0.30$0.39ViewN/AView Earnings Details
5/1/2008Q1 2008$0.10$0.20ViewN/AView Earnings Details
2/21/2008Q4 2007$0.62$0.29ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Orthofix (NASDAQ:OFIX) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Orthofix (NASDAQ OFIX) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 5.60%
Institutional Ownership Percentage: 90.09%
Insider Trading History for Orthofix (NASDAQ:OFIX)
Institutional Ownership by Quarter for Orthofix (NASDAQ:OFIX)

Orthofix (NASDAQ OFIX) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
5/3/2018Ronald A MatricariaDirectorBuy10,000$51.97$519,700.00101,613View SEC Filing  
12/11/2017Bradley V NiemannInsiderSell5,547$52.08$288,887.7634,631View SEC Filing  
11/28/2017Brad MasonCEOSell5,000$53.48$267,400.00183,053View SEC Filing  
11/6/2017Luke T FaulstickDirectorSell4,800$51.22$245,856.007,729View SEC Filing  
9/11/2017Bradley V NiemannInsiderSell6,956$49.44$343,904.6440,178View SEC Filing  
9/11/2017Rice DougCFOSell7,353$49.46$363,679.3844,743View SEC Filing  
8/21/2017Brad MasonCEOSell2,733$48.10$131,457.30188,053View SEC Filing  
8/10/2017Raymond FujikawaInsiderSell6,364$47.06$299,489.8431,084View SEC Filing  
11/10/2016Brad MasonCEOSell9,538$36.83$351,284.54151,219View SEC Filing  
9/1/2016Michael FineganInsiderSell25,000$45.16$1,129,000.0051,670View SEC Filing  
6/10/2016Maria SainzDirectorSell4,157$46.33$192,593.8120,828View SEC Filing  
6/9/2016Brad MasonCEOSell18,336$46.00$843,456.00160,256View SEC Filing  
6/8/2016Bradley V NiemannInsiderSell3,402$44.70$152,069.4025,500View SEC Filing  
5/20/2016Robert Allen Goodwin IIInsiderSell13,187$44.00$580,228.0039,607View SEC Filing  
4/18/2016Michael FineganInsiderSell80,972$42.71$3,458,314.1290,996View SEC Filing  
11/11/2015Michael FineganInsiderSell14,140$42.00$593,880.0058,252View SEC Filing  
11/6/2015Brad MasonCEOSell15,018$40.60$609,730.80140,256View SEC Filing  
11/6/2015Jeffrey SchumminsiderSell15,000$40.67$610,050.0068,882View SEC Filing  
6/2/2015Ronald A MatricariaDirectorBuy50,000$32.65$1,632,500.00View SEC Filing  
5/21/2015James F HinrichsDirectorBuy10,000$33.17$331,700.00View SEC Filing  
6/10/2014Mark A HeggestadCFOBuy13,696$33.25$455,392.00View SEC Filing  
5/17/2013Brad MasonCEOBuy5,000$26.45$132,250.00View SEC Filing  
5/17/2013Kenneth R WeisshaarDirectorBuy1,000$26.40$26,400.00View SEC Filing  
5/14/2013James GeroDirectorBuy20,000$26.37$527,400.00View SEC Filing  
2/27/2013Robert S VatersCEOBuy3,000$35.97$107,910.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Orthofix (NASDAQ OFIX) News Headlines

Source:
DateHeadline
$0.36 EPS Expected for Orthofix (OFIX) This Quarter$0.36 EPS Expected for Orthofix (OFIX) This Quarter
www.americanbankingnews.com - May 23 at 1:14 AM
Global Bone Growth Stimulator Market Growth Opportunities: DJO Finance LLC, Orthofix Holdings, ArthrexGlobal Bone Growth Stimulator Market Growth Opportunities: DJO Finance LLC, Orthofix Holdings, Arthrex
www.marketwatch.com - May 22 at 8:13 AM
Orthofix (OFIX) Director Buys $519,700.00 in StockOrthofix (OFIX) Director Buys $519,700.00 in Stock
www.americanbankingnews.com - May 7 at 10:15 AM
FY2019 EPS Estimates for Orthofix (OFIX) Lowered by SunTrust BanksFY2019 EPS Estimates for Orthofix (OFIX) Lowered by SunTrust Banks
www.americanbankingnews.com - May 7 at 5:00 AM
Orthofix (OFIX) Given Average Rating of "Buy" by AnalystsOrthofix (OFIX) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - May 7 at 1:08 AM
Orthofix (OFIX) Cut to Sell at Zacks Investment ResearchOrthofix (OFIX) Cut to Sell at Zacks Investment Research
www.americanbankingnews.com - May 5 at 2:27 PM
SunTrust Banks Comments on Orthofixs Q2 2018 Earnings (OFIX)SunTrust Banks Comments on Orthofix's Q2 2018 Earnings (OFIX)
www.americanbankingnews.com - May 4 at 7:36 AM
Orthofix (OFIX) Expected to Earn Q3 2018 Earnings of $0.45 Per ShareOrthofix (OFIX) Expected to Earn Q3 2018 Earnings of $0.45 Per Share
www.americanbankingnews.com - May 3 at 9:19 AM
Jefferies Group Analysts Decrease Earnings Estimates for Orthofix (OFIX)Jefferies Group Analysts Decrease Earnings Estimates for Orthofix (OFIX)
www.americanbankingnews.com - May 2 at 9:02 AM
Orthofix Internationals (OFIX) CEO Brad Mason on Q1 2018 Results - Earnings Call TranscriptOrthofix International's (OFIX) CEO Brad Mason on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 1 at 8:15 AM
Edited Transcript of OFIX earnings conference call or presentation 30-Apr-18 8:30pm GMTEdited Transcript of OFIX earnings conference call or presentation 30-Apr-18 8:30pm GMT
finance.yahoo.com - May 1 at 8:15 AM
Orthofix (OFIX) Issues  Earnings ResultsOrthofix (OFIX) Issues Earnings Results
www.americanbankingnews.com - April 30 at 6:48 PM
Orthofix (OFIX) Updates FY18 Earnings GuidanceOrthofix (OFIX) Updates FY18 Earnings Guidance
www.americanbankingnews.com - April 30 at 5:52 PM
Orthofix (OFIX) Issues Q2 Earnings GuidanceOrthofix (OFIX) Issues Q2 Earnings Guidance
www.americanbankingnews.com - April 30 at 5:52 PM
BRIEF-Orthofix International NV Reports Q1 EPS Of $0.27 From Continuing OperationsBRIEF-Orthofix International NV Reports Q1 EPS Of $0.27 From Continuing Operations
www.reuters.com - April 30 at 5:19 PM
Orthofix Reports First Quarter 2018 Financial ResultsOrthofix Reports First Quarter 2018 Financial Results
finance.yahoo.com - April 30 at 5:19 PM
Orthofix: 1Q Earnings SnapshotOrthofix: 1Q Earnings Snapshot
finance.yahoo.com - April 30 at 5:19 PM
Orthofix (OFIX) Set to Announce Earnings on MondayOrthofix (OFIX) Set to Announce Earnings on Monday
www.americanbankingnews.com - April 24 at 8:24 AM
Orthofix Schedules First Quarter 2018 Earnings Release and Conference Call for April 30, 2018Orthofix Schedules First Quarter 2018 Earnings Release and Conference Call for April 30, 2018
finance.yahoo.com - April 23 at 5:18 PM
BTIG Research Begins Coverage on Orthofix (OFIX)BTIG Research Begins Coverage on Orthofix (OFIX)
www.americanbankingnews.com - April 20 at 6:24 PM
$107.65 Million in Sales Expected for Orthofix (OFIX) This Quarter$107.65 Million in Sales Expected for Orthofix (OFIX) This Quarter
www.americanbankingnews.com - April 20 at 2:36 AM
 Brokerages Anticipate Orthofix (OFIX) to Announce $0.36 Earnings Per Share Brokerages Anticipate Orthofix (OFIX) to Announce $0.36 Earnings Per Share
www.americanbankingnews.com - April 18 at 3:08 PM
Orthofix (OFIX) Cut to Buy at BidaskClubOrthofix (OFIX) Cut to Buy at BidaskClub
www.americanbankingnews.com - April 16 at 7:39 AM
Orthofix International (OFIX) Rating Lowered to Hold at BidaskClubOrthofix International (OFIX) Rating Lowered to Hold at BidaskClub
www.americanbankingnews.com - April 14 at 5:18 PM
Orthofix International NV (OFIX) Given Average Rating of "Buy" by BrokeragesOrthofix International NV (OFIX) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - April 12 at 1:15 AM
Orthofix International (OFIX) Rating Increased to Buy at Zacks Investment ResearchOrthofix International (OFIX) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - April 11 at 5:01 PM
Orthofix International (OFIX) Stock Rating Upgraded by TheStreetOrthofix International (OFIX) Stock Rating Upgraded by TheStreet
www.americanbankingnews.com - April 11 at 12:42 AM
$107.65 Million in Sales Expected for Orthofix International NV (OFIX) This Quarter$107.65 Million in Sales Expected for Orthofix International NV (OFIX) This Quarter
www.americanbankingnews.com - April 3 at 3:23 AM
BTIG Research Reiterates $56.00 Price Target for Orthofix International (OFIX)BTIG Research Reiterates $56.00 Price Target for Orthofix International (OFIX)
www.americanbankingnews.com - April 2 at 9:42 PM
Orthofix International (OFIX) Upgraded by Zacks Investment Research to BuyOrthofix International (OFIX) Upgraded by Zacks Investment Research to Buy
www.americanbankingnews.com - April 2 at 10:13 AM
Orthofix International (OFIX) Stock Rating Lowered by TheStreetOrthofix International (OFIX) Stock Rating Lowered by TheStreet
www.americanbankingnews.com - April 2 at 8:39 AM
Orthofix International NV (OFIX) Expected to Announce Earnings of $0.36 Per ShareOrthofix International NV (OFIX) Expected to Announce Earnings of $0.36 Per Share
www.americanbankingnews.com - April 1 at 1:14 PM
Orthofix International (OFIX) Downgraded by Zacks Investment Research to HoldOrthofix International (OFIX) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - April 1 at 11:52 AM
Orthofix International (OFIX) Downgraded by BidaskClub to SellOrthofix International (OFIX) Downgraded by BidaskClub to Sell
www.americanbankingnews.com - March 27 at 3:28 PM
Active-Investors: Blog Exposure - FDA Cleared Orthofix Internationals G-Beam Fusion Beaming SystemActive-Investors: Blog Exposure - FDA Cleared Orthofix International's G-Beam Fusion Beaming System
www.finanznachrichten.de - March 26 at 8:14 AM
Blog Exposure - FDA Cleared Orthofix International’s G-Beam Fusion Beaming SystemBlog Exposure - FDA Cleared Orthofix International’s G-Beam Fusion Beaming System
finance.yahoo.com - March 26 at 8:14 AM
FDA clears Orthofixs new internal fixation systemFDA clears Orthofix's new internal fixation system
seekingalpha.com - March 24 at 5:21 PM
FDA Nod for Orthofixs G-Beam to Boost Extremity Fixation SBUFDA Nod for Orthofix's G-Beam to Boost Extremity Fixation SBU
finance.yahoo.com - March 24 at 5:21 PM
BRIEF-Orthofix Receives FDA 510(K) Clearance Of G-Beam Fusion Beaming SystemBRIEF-Orthofix Receives FDA 510(K) Clearance Of G-Beam Fusion Beaming System
www.reuters.com - March 22 at 8:17 AM
Orthofix Receives FDA 510(k) Clearance of G-Beam Fusion Beaming SystemOrthofix Receives FDA 510(k) Clearance of G-Beam Fusion Beaming System
finance.yahoo.com - March 22 at 8:17 AM
Brokers Issue Forecasts for Orthofix International NVs FY2020 Earnings (OFIX)Brokers Issue Forecasts for Orthofix International NV's FY2020 Earnings (OFIX)
www.americanbankingnews.com - March 20 at 4:52 PM
Orthofix International NV (OFIX) Given Consensus Rating of "Buy" by BrokeragesOrthofix International NV (OFIX) Given Consensus Rating of "Buy" by Brokerages
www.americanbankingnews.com - March 18 at 1:24 AM
 Brokerages Anticipate Orthofix International NV (OFIX) Will Announce Quarterly Sales of $107.65 Million Brokerages Anticipate Orthofix International NV (OFIX) Will Announce Quarterly Sales of $107.65 Million
www.americanbankingnews.com - March 17 at 7:11 AM
Orthofix International (OFIX) Stock Rating Upgraded by BidaskClubOrthofix International (OFIX) Stock Rating Upgraded by BidaskClub
www.americanbankingnews.com - March 16 at 11:00 PM
[$$] Orthofix Acquires Spinal Kinetics[$$] Orthofix Acquires Spinal Kinetics
finance.yahoo.com - March 16 at 6:35 PM
Orthofix Announces Agreement to Acquire Spinal KineticsOrthofix Announces Agreement to Acquire Spinal Kinetics
finance.yahoo.com - March 15 at 6:21 PM
$0.36 EPS Expected for Orthofix International N.V. (OFIX) This Quarter$0.36 EPS Expected for Orthofix International N.V. (OFIX) This Quarter
www.americanbankingnews.com - March 15 at 11:22 AM
Research Report Identifies AXT, Shire plc, Brookfield Property Partners, Copa Holdings, S.A, Turning Point Brands, and Orthofix International N.V with Renewed Outlook — Fundamental Analysis, Calculating Forward MovementResearch Report Identifies AXT, Shire plc, Brookfield Property Partners, Copa Holdings, S.A, Turning Point Brands, and Orthofix International N.V with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement
finance.yahoo.com - March 15 at 8:08 AM
Analyzing LDR (LDRH) & Orthofix International (OFIX)Analyzing LDR (LDRH) & Orthofix International (OFIX)
www.americanbankingnews.com - March 14 at 3:39 PM
Orthofix PhysioStims FDA Nod and CE Mark Boosts ProspectsOrthofix PhysioStim's FDA Nod and CE Mark Boosts Prospects
finance.yahoo.com - March 9 at 8:11 AM

SEC Filings

Orthofix (NASDAQ:OFIX) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Orthofix (NASDAQ:OFIX) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Orthofix (NASDAQ OFIX) Stock Chart for Wednesday, May, 23, 2018

Loading chart…

This page was last updated on 5/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.